An observational study evaluating the efficacy of microfragmented adipose tissue in the treatment of osteoarthritis.
Frankie FanRobert A GrantJonathan P WhiteheadAlun YewlettPaul Y F LeePublished in: Regenerative medicine (2022)
Aim: Osteoarthritis (OA) prevalence is increased in ageing and obese populations. This prospective single-arm cohort study aimed to investigate the efficacy of autologous microfragmented adipose tissue treatment of severe knee or shoulder OA. Materials & methods: Participants received an intra-articular microfragmented adipose tissue injection to the affected joint(s). Multiple patient reported outcome measures (PROMS) were recorded from 0 to 52 weeks for 63 consecutive joints. Results: Compared with baseline, there were significant improvements in all PROMS from 2 to 12 weeks and maintained at 52 weeks. Regression analysis revealed an inverse correlation with BMI and change in PROMS for knee joints. Conclusion: Our observed findings suggest this approach represents a safe, effective treatment for moderate-to-severe knee and shoulder OA, although efficacy may be reduced with increasing obesity.
Keyphrases
- adipose tissue
- knee osteoarthritis
- patient reported outcomes
- insulin resistance
- total knee arthroplasty
- type diabetes
- metabolic syndrome
- patient reported
- rheumatoid arthritis
- weight loss
- body mass index
- stem cells
- bone marrow
- weight gain
- combination therapy
- mesenchymal stem cells
- gestational age
- anterior cruciate ligament